3[1]Parolari A, Guarnieri D, Alamanni F et al. Platelet function and anesthetics in cardiac surgery: an in vitro and ex vivo study. Anesth Analg,1999,89:26
4[2]Wahba A, Black G, Kosch M et al. Cardiopulmonary bypass leads to a preferential loss of activated platelets:a flow cytometric assay of platelet surface antigens. Eur J Cardiothorac Surg, 1996 ,10 : 768
5[3]Sedlmay P, Grobhapt B, Muntean W. Flow cytometry detection of intracellular platelet antigens. Cytometry, 1996,23:284
6[4]Kestin A, Valeri R, Khuri S et al. The platelet function defect of cardiopulmonary bypass. Blood, 1993,82:107
7[5]Storck J, Hllger N, Zimmermann R. The influence of heparin and protamine sulfate on platelet ADP and platelet factor 4 release and the expression of glycoprotein Ⅱb/Ⅲa. Haemostasis, 1994,34:358
8[6]Ammar T, Fisher C. The effects of heparinase 1 and protamine on platelet reactivity. Anesthesiology, 1997,86:1382
9[7]Toshiaki M, Peter J, Olson F et al. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg, 1998,87:781
10[3]Gourin A,Streisand RL,Greinder JK,et al.Protamine sulfate administration and the cardiovascular system[J].J Thorac Cardiac Surg,1991,62:193.
